BIOAFFINITY TECHNOLOGIES, INC. ANNOUNCES APPROXIMATELY $4 MILLION REGISTERED DIRECT FINANCING OF COMMON STOCK AND CONCURRENT PRIVATE PLACEMENT PRICED AT-THE-MARKET UNDER NASDAQ RULES

Reuters · 2d ago

Please log in to view news